Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2021 - 05 - 03 save search
Protagonist Therapeutics Reports Granting of Inducement Award
Published: 2021-05-03 (Crawled : 22:00) - prnewswire.com
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: -1.3%
H: 3.05%
C: 1.8%
granted therapeutics report grant awards
iTeos Appoints Tony Ho M.D. and Robert Iannone M.D., M.S.C.E., two Highly Accomplished R&D Executives to its Board of Directors
Published: 2021-05-03 (Crawled : 21:00) - biospace.com/
ITOS | $10.58 2.42% 2.36% 940K
|
Health Technology
|
| O: 0.21%
H: 0.99%
C: -0.34%
LogicBio Announces Presentation of Retrospective Study of Disease Course in Pediatric Patients with Severe Methylmalonic Acidemia
Published: 2021-05-03 (Crawled : 21:00) - prnewswire.com
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: -1.1%
H: 1.66%
C: -6.48%
presentation disease
Entasis Therapeutics Completes Initial Closing of $20M Private Placement with Innoviva
Published: 2021-05-03 (Crawled : 21:00) - biospace.com/
INVA | $14.955 1.8% 1.77% 640K
|
Health Technology
|
| O: 1.14%
H: 0.69%
C: 0.6%
ETTX | $2.19 -0.46% 0.46%
|
Health Technology
|
| O: 2.63%
H: 0.0%
C: -1.86%
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-05-03 (Crawled : 20:00) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: -1.73%
H: 0.59%
C: -0.59%
granted grant
Excision BioTherapeutics Appoints Seasoned Finance Executive Christine Silverstein as Chief Financial Officer
Published: 2021-05-03 (Crawled : 15:00) - biospace.com/
RLMD | $4.0 -6.98% -7.5% 150K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -1.85%
iot
Himalaya Therapeutics Announces Appointment of Howe Li as Chief Medical Officer
Published: 2021-05-03 (Crawled : 14:15) - prnewswire.com
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.39%
H: 0.09%
C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
Regulus Therapeutics Announces Top-Line Data from the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
RGLS | $2.13 -4.05% -4.23% 220K
|
Health Technology
|
| O: -2.16%
H: 2.18%
C: -17.65%
disease treatment phase 1 trial topline phase 1b kidney phase 2b
Hoth Therapeutics Announces Development of HT-KIT to Treat Multiple Orphan Diseases, Including Rare Cancers
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 9.01%
H: 6.32%
C: -6.44%
disease cancer rare
Arcturus Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 10, 2021
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: 0.6%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.53%
H: 1.05%
C: 0.98%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: 1.31%
H: 0.16%
C: -3.12%
financial results results
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: 0.6%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -1.56%
H: 3.87%
C: 2.68%
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial OfficerCompany Prepares for Next Stage of Growth
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 0.24%
H: 4.49%
C: -1.7%
growth
Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -0.36%
H: 1.3%
C: -3.17%
financial results results
Revance to Release First Quarter 2021 Financial Results on Monday, May 10, 2021
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: 0.93%
H: 0.17%
C: -1.94%
financial results results ev
Kymera Therapeutics Presents Positive Late-Breaking Data from Non-Interventional Study in Patients with Hidradenitis Suppurativa at the Society for Investigative Dermatology 2021 Annual Meeting
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: -4.46%
positive
OpRegen® Clinical Data Continues to Demonstrate Improvements in Patients With Dry AMD With Geographic Atrophy
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -4.66%
dmd
Sarepta Therapeutics Reports Positive Clinical Results from Phase 2 MOMENTUM Study of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: 0.58%
H: 10.2%
C: 8.22%
phase 2 positive results duchenne
Calliditas promotes Andrew Udell to President, North America
Published: 2021-05-03 (Crawled : 12:57) - prnewswire.com
CALT | $17.65 -2.4% 4K
|
Health Technology
|
| O: 1.42%
H: 0.57%
C: -0.07%
BioXcel Therapeutics to Host First Quarter 2021 Operating and Financial Results Conference Call and Webcast
Published: 2021-05-03 (Crawled : 12:15) - biospace.com/
BTAI | $2.77 8.63% 7.94% 620K
|
Health Technology
|
| O: 1.12%
H: 0.73%
C: -4.31%
financial results results conference
Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
Published: 2021-05-03 (Crawled : 12:15) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: 0.6%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -1.56%
H: 3.87%
C: 2.68%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
SIX | $23.45 -0.55% 0.68% 650K
|
Consumer Services
KNSL 4 | $451.81 -0.02% 0.49% 140K
|
Finance
SENS | $0.3992 -4.04% 0.45% 2M
|
Electronic Technology
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.